thiorphan has been researched along with lisinopril in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, NM; Costall, B; Egli, P; Horovitz, ZP; Ironside, JW; Naylor, RJ; Williams, TJ | 1 |
| Dasarathy, Y; Fanburg, BL; Lanzillo, JJ; Stevens, J | 1 |
| Gao, XP; Olopade, CO; Pakhlevaniants, S; Rubinstein, I; Suzuki, H | 1 |
| Cibulsky, SM; Thompson, DC | 1 |
| Hayashi, I; Ito, H; Izumi, T; Katori, M; Majima, M; Nakajima, S | 1 |
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Acharya, KR; Cozier, GE; Sharma, U; Sturrock, ED | 1 |
1 review(s) available for thiorphan and lisinopril
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
6 other study(ies) available for thiorphan and lisinopril
| Article | Year |
|---|---|
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Brain; Captopril; Enalapril; Female; Fosinopril; Humans; Kinetics; Lisinopril; Male; Middle Aged; Organophosphorus Compounds; Proline; Rats; Thiorphan | 1991 |
A peptidyl dipeptidase-4 from Pseudomonas maltophilia: purification and properties.
Topics: Chromatography; Enalapril; Endopeptidases; Hydrogen-Ion Concentration; Isoelectric Point; Kinetics; Lisinopril; Molecular Weight; Protease Inhibitors; Pseudomonas; Salts; Substrate Specificity; Thiorphan | 1989 |
Angiotensin-converting enzyme and neutral endopeptidase modulate smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa in vivo.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Capillary Permeability; Captopril; Cricetinae; Dextrans; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Glycopeptides; Lisinopril; Male; Mesocricetus; Microcirculation; Mouth Mucosa; Neprilysin; Peptidyl-Dipeptidase A; Plants, Toxic; Protease Inhibitors; Thiorphan; Tobacco, Smokeless | 1997 |
Absence of tachykinin involvement in leukotriene D4 and antigen-induced contraction of guinea pig isolated bronchus.
Topics: Animals; Antigens; Bronchi; Guinea Pigs; In Vitro Techniques; Leukotriene D4; Lisinopril; Male; Muscle Contraction; Tachykinins; Thiorphan | 1997 |
Effect of prolonged administration of a urinary kinase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Carboxypeptidases; Cathepsin A; Desoxycorticosterone; Drinking; Heart; Heart Ventricles; Hypertension; Kallikreins; Kidney; Kinins; Lactones; Lisinopril; Male; Organ Size; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Thiorphan; Time Factors; Urination; Water-Electrolyte Balance | 1999 |
Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Crystallography, X-Ray; Drug Design; Mesylates; Neprilysin; Peptidyl-Dipeptidase A; Protein Binding; Protein Structure, Secondary; Pyridines; Thiazepines; Tyrosine | 2020 |